Advances in Cardiometabolic Health
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Cellular Biochemistry".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 67
Special Issue Editors
2. Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, 20099 Sesto San Giovanni and Ospedale San Giuseppe, Milan, MI, Italy
Interests: insulin signalling; nutrition; obesity; type 2 diabetes; cardiometabolic disorders; physical exercise; organokines
Special Issues, Collections and Topics in MDPI journals
2. Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, 20099 Sesto San Giovanni and Ospedale San Giuseppe, Milan, MI, Italy
Interests: obesity; type 2 diabetes; metabolic diseases; obesity treatment; neuromodulation; eating behaviour; cardiovascular diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Obesity represents a major global health concern in relation to cardiometabolic disorders. Currently, the worldwide obesity rate (more than 1 billion people) has nearly doubled since 1980, and one in five women and one in seven men will have obesity by 2030.
Growing evidence indicates that personalized diets, according to the individual's genotype, age and/or enterotype, represent the optimal therapeutic strategy to counteract obesity. In addition, training personalized programs are needed to improve nutritional strategies.
However, therapeutic lifestyle changes are often inadequate.
Recently, certain pharmacological therapy as an adjunct to lifestyle modifications has been approved. In addition, different type 2 diabetes drugs, GLP-1 agonists and SGLT-2 inhibitors, lead to weight loss and protect cardiac function. Moreover, bariatric surgery is an efficacy strategy to reduce obesity-related risks in severe obesity.
Finally, different innovative approaches, as neuromodulation or artificial intelligence (AI)-based platforms, are testing to improve cardiometabolic health.
In this Special Issue, we will focus on novel strategies to maintain cardiometabolic health through the development of personalized treatments.
We will also investigate the interplay between nutrient intake, dietary pattern consumption, exercise and drugs with cellular mechanisms that affect appetite, thermogenesis and metabolism.
Reviews, original research articles and communications are welcome.
Dr. Pamela Senesi
Dr. Anna Ferrulli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- cardiovascular diseases
- biomarkers
- lifestyle interventions
- personalized medicine
